News
![DGAP-News: CompuGroup Medical publishes Annual Report for 2021 and proposes dividend at prior year's level](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
DGAP-News: CompuGroup Medical publishes Annual Report for 2021 and proposes dividend at prior year's level
DGAP-News: CompuGroup Medical publishes Annual Report for 2021 and proposes dividend at prior year's level
![Sistema PJSFC: Sistema announces financial results for the fourth quarter and FY 2021](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Sistema PJSFC: Sistema announces financial results for the fourth quarter and FY 2021
Sistema PJSFC: Sistema announces financial results for the fourth quarter and FY 2021
![DGAP-News: DEFENCE THERAPEUTICS ANNOUNCES ISSUANCE OF A U.S. PATENT COVERING ITS PIONEERING VACCINE PLATFORM TECHNOLOGY](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
DGAP-News: DEFENCE THERAPEUTICS ANNOUNCES ISSUANCE OF A U.S. PATENT COVERING ITS PIONEERING VACCINE PLATFORM TECHNOLOGY
DGAP-News: DEFENCE THERAPEUTICS ANNOUNCES ISSUANCE OF A U.S. PATENT COVERING ITS PIONEERING VACCINE PLATFORM TECHNOLOGY
![OPG Power Ventures (OPG): Management succession and update](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
OPG Power Ventures (OPG): Management succession and update
OPG Power Ventures (OPG): Management succession and update
![Cairn Homes Plc: Transaction in Own Shares](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
![Biophytis provides updates on Sarconeos (BIO101) clinical development](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Biophytis provides updates on Sarconeos (BIO101) clinical development
Biophytis provides updates on Sarconeos (BIO101) clinical development
![DGAP-News: Multitude SE is contemplating a subsequent bond issue](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
DGAP-News: Multitude SE is contemplating a subsequent bond issue
DGAP-News: Multitude SE is contemplating a subsequent bond issue
![Travis Perkins: Transaction in Own Shares](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
![Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives
Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives
![DGAP-News: BAUER Aktiengesellschaft: BAUER AG achieves an increase in total Group revenues for 2021 despite challenging market conditions](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
DGAP-News: BAUER Aktiengesellschaft: BAUER AG achieves an increase in total Group revenues for 2021 despite challenging market conditions
DGAP-News: BAUER Aktiengesellschaft: BAUER AG achieves an increase in total Group revenues for 2021 despite challenging market conditions
![ASMALLWORLD AG invites shareholders to the Annual General Meeting](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
ASMALLWORLD AG invites shareholders to the Annual General Meeting
ASMALLWORLD AG invites shareholders to the Annual General Meeting
![Baloise shares its know-how with start-up founders](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Baloise shares its know-how with start-up founders
Baloise shares its know-how with start-up founders
![DGAP-News: NFON AG repositions itself in the growing market for integrated business communications](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
DGAP-News: NFON AG repositions itself in the growing market for integrated business communications
DGAP-News: NFON AG repositions itself in the growing market for integrated business communications
![Ad-hoc announcement pursuant to Art. 53 LR: Jungfrau Railway Group achieves virtually break-even result](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Ad-hoc announcement pursuant to Art. 53 LR: Jungfrau Railway Group achieves virtually break-even result
Ad-hoc announcement pursuant to Art. 53 LR: Jungfrau Railway Group achieves virtually break-even result
![DGAP-Adhoc: Eckert & Ziegler Publishes Preliminary Figures for Q1/2022 with Deviation in Earnings and Confirms Annual Forecast for 2022](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
DGAP-Adhoc: Eckert & Ziegler Publishes Preliminary Figures for Q1/2022 with Deviation in Earnings and Confirms Annual Forecast for 2022
DGAP-Adhoc: Eckert & Ziegler Publishes Preliminary Figures for Q1/2022 with Deviation in Earnings and Confirms Annual Forecast for 2022
![DGAP-Adhoc: Enapter AG: Announcement Capital Increase](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
DGAP-Adhoc: Enapter AG: Announcement Capital Increase
DGAP-Adhoc: Enapter AG: Announcement Capital Increase
![Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
![GEVELOT S.A.: PRESS RELEASE CLOSING OF 2021 ACCOUNTS](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2021 ACCOUNTS
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2021 ACCOUNTS
![DGAP-News: Abivax reports excellent one-year efficacy and safety data of ABX464 phase 2b maintenance trial in ulcerative colitis](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
DGAP-News: Abivax reports excellent one-year efficacy and safety data of ABX464 phase 2b maintenance trial in ulcerative colitis
DGAP-News: Abivax reports excellent one-year efficacy and safety data of ABX464 phase 2b maintenance trial in ulcerative colitis
![ENERGISME: Results 2021 - Revenues of €3.46 million, up 71% from 2020.](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
ENERGISME: Results 2021 - Revenues of €3.46 million, up 71% from 2020.
ENERGISME: Results 2021 - Revenues of €3.46 million, up 71% from 2020.
![Holding(s) in Company](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Holding(s) in Company
Holding(s) in Company
![DGAP-Adhoc: InCity Immobilien AG: ON THE BASIS OF INTERIM FIGURES FOR 2021, INCITY ACHIEVES A CONSOLIDATED NET INCOME OF APPROX. EUR 1.0 M AND A NET INCOME OF APPROX. EUR 2.1 M IN THE SINGLE-ENTITY COMPANY](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
DGAP-Adhoc: InCity Immobilien AG: ON THE BASIS OF INTERIM FIGURES FOR 2021, INCITY ACHIEVES A CONSOLIDATED NET INCOME OF APPROX. EUR 1.0 M AND A NET INCOME OF APPROX. EUR 2.1 M IN THE SINGLE-ENTITY COMPANY
DGAP-Adhoc: InCity Immobilien AG: ON THE BASIS OF INTERIM FIGURES FOR 2021, INCITY ACHIEVES A CONSOLIDATED NET INCOME OF APPROX. EUR 1.0 M AND A NET INCOME OF APPROX. EUR 2.1 M IN THE SINGLE-ENTITY COMPANY
![DGAP-News: Burcon Receives NASDAQ Letter Regarding Minimum Bid Price Deficiency](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
DGAP-News: Burcon Receives NASDAQ Letter Regarding Minimum Bid Price Deficiency
DGAP-News: Burcon Receives NASDAQ Letter Regarding Minimum Bid Price Deficiency
![Alzchem Group AG: International Creatine Conference 2022](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Alzchem Group AG: International Creatine Conference 2022
Alzchem Group AG: International Creatine Conference 2022
![WICKES GROUP PLC: Director/PDMR Shareholding](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
WICKES GROUP PLC: Director/PDMR Shareholding
WICKES GROUP PLC: Director/PDMR Shareholding